Hans Juerg Wuethrich

Title: Innovations by Hans Juerg Wuethrich

Introduction

Hans Juerg Wuethrich is a notable inventor based in Kehrsatz, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of chemokine receptor antagonists. With a total of 2 patents to his name, Wuethrich's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Wuethrich's latest patents focus on chemokine receptor antagonists. The first patent describes a compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof, wherein the variants R, R9, Z, X, Q, and Y are defined in the specification. The second patent also pertains to chemokine receptor antagonists, detailing a similar compound of formula (I) with the same defined variants.

Career Highlights

Wuethrich is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore innovative solutions in drug development, particularly in the area of receptor antagonists. His contributions are recognized within the pharmaceutical community for their potential therapeutic benefits.

Collaborations

Some of Wuethrich's notable coworkers include Philipp Janser and Emil Pfenninger. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical sector.

Conclusion

Hans Juerg Wuethrich's innovative work in chemokine receptor antagonists showcases his commitment to advancing medical science. His patents reflect a dedication to improving therapeutic options for patients.